Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Glenmark Pharmaceuticals — Glenmark Specialty S.A.
Entity

Glenmark Pharmaceuticals — Glenmark Specialty S.A.

Tracked across 1 events · 6 articles · First seen Jun 11, 2026 · Last active Jun 11, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 60
Business
Glenmark launches Winlevi in Europe
Glenmark Pharmaceuticals, through its subsidiary Glenmark Pharmaceuticals — Glenmark Specialty S.A., has launched Winlevi (clascoterone 10 mg/g cream) in key European markets for the treatment of acne vulgaris. This launch follows the International — European…
Impact: Glenmark Pharmaceuticals — Glenmark Specialty S.A., a wholly-owned subsidiary of Glenmark Pharmaceuticals, is directly responsible for the launch of Winlevi across several European markets.
Jun 11, 2026 · 6 articles
NEWSDESK
Track Glenmark Pharmaceuticals — Glenmark Specialty S.A. live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.